33
/fr/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512550
319423
2
Public Timelines
FAQ Obtenir le Premium

1 janv. 1997 - Rituximab

Description:

For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.

Ajouté au bande de temps:

14 nov. 2019
0
0
299

Date:

1 janv. 1997
Maintenaint
~ Il y a 28 ans